This case not only recognizes the recently identified link between SGLT-2 inhibitors and pancreatitis, but it also depicts the accelerated sequela into hyperglycemic hyperosmolar syndrome (HHS) caused by pancreatitis. This evidence concerns the gene SLC5A2 and pancreatitis.